Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. YU. ZLATNIK
The POSSIBILITY OF USING TUMOR NECROSIS FACTOR-THYMOSIN-α1 IN NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER
Medical Council
Related publications
Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Neoadjuvant Chemotherapy in Breast Cancer
Neoadjuvant Chemotherapy: Role in Breast Cancer
Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Medical – Clinical Research & Reviews
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Assessment of a Breast Cancer Response to Neoadjuvant Chemotherapy Using Backscatter Ultrasound Statistics
Neoadjuvant Chemotherapy for Early Breast Cancer – Author's Reply
The Lancet Oncology
Oncology
Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer
Oncotarget
Oncology